Understanding your genetic predispositions helps PlexusDx clinicians optimize your starting dose and anticipate side-effect profiles tailored to your biology
But if youre sensitive to caffeine, you might need to drink less than that
While this caloric deficit is instrumental for weight loss, it simultaneously increases the risk of losing valuable lean muscle mass
With this decision, Wegovy becomes the first GLP-1 receptor agonist approved in both India and globally for this patient population
All patients were studied in a supine position, measurements of the gastric antrum were always taken from the outer profile of the wall because the lumen of the antrum is usually very narrow, the cross section of the gastric antrum was measured, corresponding to the antral diameter, (forms an elliptical shape)
About the SYNCHRONIZE-1 trial (NCT06066515) This is a Phase III, double-blind, placebo-controlled 76-week efficacy and safety trial of survodutide among 725 adults living with obesity or overweight, without type 2 diabetes